Welcome!
Welcome to the new CancerGRACE.org! Explore our fresh look and improved features—take a quick tour to see what’s new.
Jonathan W. Riess, MD MS is Associate Professor of Medicine in the Division of Hematology/Oncology at UC Davis Comprehensive Cancer Center. Sukhmani Padda MD is Assistant Professor of Medicine (Oncology) at the Stanford University Medical Center. In this video series, the doctors discuss a series of cases related to a diagnosis of ALK Positive NSCLC. This next panel discussion is regarding progression after success on an ALK inhibitor. Do you continue the ALK inhibitor when transitioning to a chemo based treatment?

Please feel free to offer comments and raise questions in our
discussion forums.
Hi James Anthony, I'm so sorry you are going through this and so very young. It' s true that some people benefit for years with chemo and targeted therapies. With the...
Hi siigs, I'm sorry you're having health issues. They don't sound like pancoast tumor symptoms. A consult with a pulmonologist can help to understand your chest symptoms and work toward alleviating...
Hi Lonnie,
Yes, the info in last year's OncTalk was up to date at that moment. I think it would be well worth the watch along with videos in our 2025...
Welcome to the new CancerGRACE.org! Explore our fresh look and improved features—take a quick tour to see what’s new.